Mainstreet Investment

Investing in Tomorrow's Breakthroughs

We pursue rigorous investments to maximize lasting value for our investors.

About

A Disciplined Approach to Growth Equity

Mainstreet Investment is a private equity firm focused on growth-stage and pre-IPO investments. Established in 2019, MSI partners with exceptional companies to drive long-term value creation through active portfolio management and strategic support. Our approach combines deep sector expertise with a disciplined investment framework, targeting opportunities where we can drive meaningful operational and strategic improvements.

Growth Equity Pre-IPO Buyout Mezzanine

Investment Focus Areas

Healthcare & Life Sciences

Transforming healthcare delivery through technology innovation — medical AI, digital health, and biomedical engineering at the intersection of technology and patient care.

Deep Tech & Advanced Materials

Foundational technologies in semiconductors, advanced materials, and precision components where proprietary know-how creates durable competitive advantages.

Consumer & Lifestyle Brands

Global consumer brands poised for operational transformation and international expansion, combining strategic repositioning with hands-on operational support.

Digital Platforms & Software

Technology platforms that connect ecosystems and create network effects at scale, with global operating experience across major technology markets.

Content & Media

Content-driven businesses spanning entertainment, IP, and digital media, leveraging extensive networks across global studios, publishers, and distribution.

History

Our Journey

2019
Founded as a private equity firm focused on technology and growth investments
2020
Launched first project funds; Established subsidiary Mainstreet Ventures
2021
Expanded fund portfolio with digital life and AgTech focused investment vehicles
2022
Formed strategic partnerships with institutional co-investors across technology sectors
2024
Appointed Bogi Park as Co-CEO; Strengthened deal execution with Chanyoung Choi joining as MD
2025
Cumulative AUM surpassing KRW 196 billion across 27+ funds with 20+ institutional LPs

Investment Process

01
Deal Sourcing & Screening
Identifying companies with strong fundamentals, innovative business models, and scalable market potential.
02
Analysis & Due Diligence
Comprehensive analysis through preliminary and full investment committee review, followed by thorough due diligence.
03
Post-Investment & Value Creation
Systematic portfolio management focused on enhancing enterprise value through strategic support.
04
Exit
Pursuing optimal exit strategies including IPO, M&A, secondary sales, and other flexible approaches.
Portfolio

Selected Investments

Blind Blind WATCHBOX WATCHBOX Ninjacart Ninjacart Bitsmedia Bitsmedia Greenlabs Greenlabs Mono Labs Mono Labs Library Company Library Company
Team

Leadership

SP
Soonwoo Park
CEO & Founder
BA in Business Administration, Korea University

Former executive at Alibaba (NYSE), VP at The 9 (NASDAQ), Managing Director at LB Investment
BP
Bogi Park
Co-CEO, Head of Investments
PhD in Biomedical Engineering, Korea University

Former Senior Team Lead at KB Investment PE Division, VP at Shinhan Bank GIB, Manager at Hanwha Asset Management
CC
Chanyoung Choi
Director
BA in Business Administration, Korea University

Former at J.P. Morgan Seoul & Hong Kong (8 years), Senior Consultant at Oliver Wyman, Director at Centroid Investment Partners
SK
Seungsu Kang
Executive Director
BA in Public Law, Seoul National University

Former Chairman & CEO of Hanssem
HK
Heejin Ku
Senior Advisor
BA in International Trade, Hankuk University of Foreign Studies

Former CEO of Daishin Asset Management, Vice Chairman of DB Financial Group

Get in Touch

6F, 24 Eonju-ro 85-gil, Gangnam-gu, Seoul 06221, Korea
+82-2-569-9181  /  Fax +82-2-569-9182